Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.

Huda Salman · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
carcelltherapy
chronic myelomonocytic leukemia, t cell, cell therapy, car-t, chimeric antigen, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 993908
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.